Skip to content

IMTX

Immatics N.V.

NASDAQ · Healthcare · Biotechnology · DE

$9.56
+1.06%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue41.7M48.3M155.8M54.0M172.8M
Cost of Revenue
Gross Profit41.7M48.3M155.8M54.0M172.8M
Operating Expenses
R&D Expense218.4M183.8M148.1M118.7M106.8M
SG&A Expense54.8M51.2M46.4M38.2M36.1M
General & Admin Expense54.8M51.2M46.4M38.2M36.1M
Selling & Marketing Expense
Other Expenses(4.7M)(4.7M)(78.0K)(1.1M)(26.0K)
Total Operating Expenses268.5M230.3M194.4M155.7M142.9M
Cost and Expenses268.5M230.3M194.4M155.7M142.9M
Operating Income (EBIT)(226.8M)(182.0M)(38.6M)(101.7M)30.0M
Non-Operating
Interest Income14.3M17.2M25.0M13.8M2.5M
Interest Expense868.0K946.0K886.0K831.0K1.0M
Net Interest Income13.5M16.2M24.1M13.0M1.4M
Other Non-Op Income/Expense20.0M(16.4M)60.0M4.7M12.1M
Non-Operating Income (excl Interest)(20.9M)15.5M(60.8M)(5.6M)(13.1M)
EBT (Pre-Tax Income)(206.8M)(198.4M)21.3M(97.0M)42.0M
Income Tax Expense(215.0K)(2.0M)6.1M(2.3M)14.3M
Bottom Line
Net Income(206.5M)(196.4M)15.2M(94.6M)27.7M
Earnings from Cont. Ops(206.5M)(196.4M)15.2M(94.6M)27.7M
Earnings from Discont. Ops
Bottom Line Net Income(206.5M)(196.4M)15.2M(94.6M)27.7M
Per Share
Basic EPS($1.59)($1.54)$0.14($1.18)$0.56
Diluted EPS($1.59)($1.54)$0.14($1.18)$0.55
Revenue Per Share$0.31$0.39$1.46$0.67$2.58
Shares
Basic Shares Outstanding136.7M122.3M106.8M80.5M67.0M
Diluted Shares Outstanding136.7M122.3M106.8M80.5M68.2M
Profitability Metrics
EBITDA(193.8M)(185.1M)34.5M(88.9M)50.0M
D&A12.1M12.4M12.2M7.2M7.0M
EBIT(205.9M)(197.5M)22.2M(96.2M)43.1M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026